Abstract
Tumor suppressor p53 is a transcription factor that induces growth arrest and/or apoptosis in response to cellular stress. To identify novel p53-inducible genes, we compared the expression of genes in normal mouse embryo fibroblasts (MEFs) to p53-null cells by cDNA representational difference analysis. We report here that expression of endogenous sodium channel subunit beta 3 (SCN3B) is upregulated in mouse embryonic fibroblasts by DNA damage in a p53-dependent manner. In addition, we found that SCN3B levels are upregulated in human cancer cell lines by DNA damaging agents, as well as by overexpression of p53, but not significantly by p63 or p73. Furthermore, we identified two putative p53-binding sites upstream of the first exon (RE1) and in the third intron (RE2). The p53 protein can directly interact with the putative p53-binding sites in vivo, as assessed by chromatin immunoprecipitation. A reporter gene assay revealed that these two p53-binding sites are functional response elements. The SCN3B protein appears to be localized to the endoplasmic reticulum (ER). Introduction of the SCN3B gene into T98G and Saos2 cells potently suppressed colony formation. Furthermore, we found that adenovirus-mediated transfer of SCN3B induced apoptosis when combined with anticancer agents. The results presented here suggest that SCN3B mediates a p53-dependent apoptotic pathway and may be a candidate for gene therapy combined with anticancer drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agami R, Blandino G, Oren M and Shaul Y . (1999). Nature, 399, 809–813.
Bourden JC, Renzing J, Robertson PL, Fernandes KN and Lane DP . (2002). J. Cell Biol., 158, 235–246.
Catterall WA . (2000). Neuron, 26, 13–25.
El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B . (1992). Nat. Genet., 1, 45–49.
Ferri KF and Kroemer G . (2001). Nat. Cell Biol., 3, E255–263.
Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M and Wang JY . (1999). Nature, 399, 806–809.
Hollstein M, Sidransky D, Vogelstein B and Harris CC . (1991). Science, 253, 49–53.
Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC and Kaelin Jr WG . (2003). Cancer Cell, 3, 403–410.
Ishida S, Yamashita T, Nakaya U and Tokino T . (2000). Jpn. J. Cancer Res., 91, 174–180.
Isom LL, De Jongh KS, Patton DE, Reber BF, Offord J, Charbonneau H, Walsh K, Goldin AL and Catterall WA . (1992). Science, 256, 839–842.
Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, Scheuer T and Catterall WA . (1995). Cell, 83, 433–442.
Kaufman RJ . (1999). Gene. Dev., 13, 1211–1233.
Lin Y, Ma W and Benchimol S . (2000). Nat. Genet., 26, 122–127.
Miyashita T and Reed JC . (1995). Cell, 80, 293–299.
Morgan K, Stevens EB, Shah B, Cox PJ, Dixon AK, Lee K, Pinnock RD, Hughes J, Richardson PJ, Mizuguchi K and Jackson AP . (2000). Proc. Natl. Acad. Sci. USA, 97, 2308–2313.
Morimoto I, Sasaki Y, Ishida S, Imai K and Tokino T . (2002). Gene. Chromosome Cancer, 33, 270–278.
Nakano K and Vousden KH . (2001). Mol. Cell, 7, 683–694.
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N . (2000a). Science, 288, 1053–1058.
Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y . (2000b). Cell, 102, 849–862.
Owen-Schaub LB, Angelo LS, Radinsky R, Ware CF, Gesner TG and Bartos DP . (1995). Cancer Lett., 94, 1–8.
Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y and Tokino T . (2002). J. Biol. Chem., 277, 719–724.
Sasaki Y, Itoh F, Suzuki H, Kobayashi T, Kakiuchi H, Hareyama M and Imai K . (2000). J. Clin. Lab. Anal., 14, 314–319.
Sasaki Y, Mita H, Toyota M, Ishida S, Morimoto I, Yamashita T, Tanaka T, Imai K, Nakamura Y and Tokino T . (2003). Cancer Res., 63, 8145–8152.
Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K and Tokino T . (2001). Gene Ther., 8, 1401–1408.
Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T and Korsmeyer SJ . (2003). Science, 300, 135–139.
Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF and Karin M . (2000). Cell, 103, 897–907.
Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and El-Deiry WS . (1997). Nat. Genet., 17, 141–143.
Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B . (2001). Mol. Cell, 7, 673–682.
Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D . (1999). Nature, 399, 814–817.
Acknowledgements
We are grateful to Dr Motoya Katsuki for MEFs from p53 nullizygote mice and Dr Bert Vogelstein for HCT116-p53(−/−) cell lines. We also thank Dr Joseph F. Costello for valuable discussion in this study. This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MT, YH, KI and TT).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adachi, K., Toyota, M., Sasaki, Y. et al. Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene 23, 7791–7798 (2004). https://doi.org/10.1038/sj.onc.1208067
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208067
Keywords
This article is cited by
-
Genomic view of the origins of cell-mediated immunity
Immunogenetics (2023)
-
Contribution of voltage-gated sodium channel β-subunits to cervical cancer cells metastatic behavior
Cancer Cell International (2019)
-
Sodium Channel Nav1.5 Controls Epithelial-to-Mesenchymal Transition and Invasiveness in Breast Cancer Cells Through its Regulation by the Salt-Inducible Kinase-1
Scientific Reports (2019)
-
Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells
BMC Cardiovascular Disorders (2016)
-
RNA-seq analysis of broiler liver transcriptome reveals novel responses to high ambient temperature
BMC Genomics (2014)